PA Capital LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
PA Capital LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$756,000
-9.2%
7,758
+45.4%
0.53%
-11.9%
Q2 2020$833,000
+4.3%
5,336
-3.6%
0.60%
-14.7%
Q1 2020$799,000
+0.6%
5,538
+42.6%
0.71%
+0.7%
Q4 2019$794,000
+113.4%
3,884
-16.3%
0.70%
+91.8%
Q3 2019$372,000
-45.2%
4,642
-35.5%
0.37%
-40.8%
Q2 2019$679,000
-19.5%
7,196
-27.1%
0.62%
-30.2%
Q1 2019$844,000
+9.2%
9,871
-28.4%
0.89%
+8.4%
Q4 2018$773,00013,7860.82%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders